These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6971702)

  • 1. Normal computed tomograms of the brain in osteosarcoma patients treated with high-dose methotrexate.
    Bowles D; Pratt C; Evans W; Price RA; Coburn T
    Cancer; 1981 Apr; 47(7):1762-5. PubMed ID: 6971702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose systemic methotrexate-associated acute neurologic dysfunction.
    Packer RJ; Grossman RI; Belasco JB
    Med Pediatr Oncol; 1983; 11(3):159-61. PubMed ID: 6602269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy for osteosarcoma.
    Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S
    Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug chemotherapy in pulmonary treatment of osteosarcoma.
    Sutow WW; Gehan EA; Vietti TJ; Frias AE; Dyment PG
    J Bone Joint Surg Am; 1976 Jul; 58(5):629-33. PubMed ID: 1084348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E; Wilbur JR
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of leucovorin rescue to prevent reactivation of a solar burn after high dose methotrexate.
    Corder MP; Stone WH
    Cancer; 1976 Apr; 37(4):1660-2. PubMed ID: 1083286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma.
    Pratt CB; Howarth C; Ransom JL; Bowles D; Green AA; Kumar AP; Rivera G; Evans WE
    Cancer Treat Rep; 1980 Jan; 64(1):11-20. PubMed ID: 6966535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between dose of folinic acid and neurotoxicity in children and adolescents treated for osteosarcoma with high-dose methotrexate (HDMTX): a neuropsychological and psychosocial study.
    Bonda-Shkedi E; Arush MW; Kaplinsky C; Ash S; Goshen Y; Yaniv I; Cohen IJ
    J Pediatr Hematol Oncol; 2013 May; 35(4):271-5. PubMed ID: 23612378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.
    Chessells JM; Cox TC; Kendall B; Cavanagh NP; Jannoun L; Richards S
    Arch Dis Child; 1990 Apr; 65(4):416-22. PubMed ID: 2346334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of adjuvant chemotherapy in osteogenic osteosarcoma: comparison of altering sequential administrations of high doses of adriamycin, methotrexate, and cyclophosphamide with a 6-month administration of high-dose adriamycin followed by a low-dose semicontinuous chemotherapy. EORTC Osteosarcoma Working Party Group.
    Recent Results Cancer Res; 1978; 68():28-32. PubMed ID: 288108
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
    Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
    Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose methotrexate for osteosarcoma: toxicity and clinical results.
    Breithaupt H; Küenzlen E
    Oncology; 1983; 40(2):85-9. PubMed ID: 6600827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue.
    Allen JC; Rosen G; Mehta BM; Horten B
    Cancer Treat Rep; 1980; 64(12):1261-73. PubMed ID: 6970616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
    Kickinger W; Ritschl P; Kotz R
    Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient neurologic disturbances induced by high-dose methotrexate treatment.
    Jaffe N; Takaue Y; Anzai T; Robertson R
    Cancer; 1985 Sep; 56(6):1356-60. PubMed ID: 3875390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma.
    Delepine N; Delepine G; Cornille H; Brion F; Arnaud P; Desbois JC
    Anticancer Res; 1995; 15(2):489-94. PubMed ID: 7763028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
    Levine AS; Appelbaum FR; Graw RG; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
    Cancer Treat Rep; 1978 Feb; 62(2):247-50. PubMed ID: 346213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
    Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
    Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.